---
schema_version: "secwatch.filing_event.v1"
accession: "0001757073-23-000078"
form_type: "8-K"
ticker: "NVST"
cik: "0001757073"
company_name: "Envista Holdings Corp"
filed_at: "2023-12-14T23:59:59+00:00"
generated_at: "2026-06-07T12:55:47.943871+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Envista names three new executives; Nobel Biocare president exits Dec 31

## Summary
- Patrik Eriksson, SVP and President of Nobel Biocare, departs effective Dec 31, 2023.
- Robert Befidi appointed President, Diagnostics; previously led division at 3M.
- Suraj Satpathy appointed Chief Human Resources Officer; formerly SVP HR at Cepheid.
- Andrew Chen appointed Chief Information Officer; previously CIO at Kite Pharma.
- External search for permanent CFO is underway; CEO Aghdaei directly overseeing Nobel Biocare.

## SEC filing metadata
- accession: 0001757073-23-000078
- form_type: 8-K
- ticker: NVST
- cik: 0001757073
- company_name: Envista Holdings Corp
- filed_at: 2023-12-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757073/000175707323000078/0001757073-23-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757073/000175707323000078/nvst-20231211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757073-23-000078
- JSON: https://secwatch.observer/filing/0001757073-23-000078.json
- Plain text: https://secwatch.observer/filing/0001757073-23-000078.txt

## Key facts
- Executive change
  Patrik Eriksson resigned as SVP and President, Nobel Biocare at Envista Holdings Corp.
  - Action: resigned
  - Role: SVP and President, Nobel Biocare
  source text: On December 11, 2023, Envista Holdings Corporation (the “Company”) and Patrik Eriksson, the Company’s SVP and President, Nobel Biocare, mutually agreed that Mr. Eriksson’s employment will terminate effective December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757073/000175707323000078/0001757073-23-000078-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.